biochimica clinica

en_US English
en_US English it_IT Italian

LETTERE ALL’EDITORE - Letters to the Editors

Volume:

Biochimica Clinica, 2024; 48(1) 101-103

Pubblicato on-line:

February 12, 2024

DOI:

10.19186/BC_2024.008

Scarica in PDF:
Autenticazione richiesta

Considerazioni sulle modalità di refertazione del tempo di protrombina e del tempo di tromboplastina parziale attivato

AUTORI

Benedetto Morelli1, Barbara Montaruli2, Paola Calzoni3, Paola Pradella4, Claudia Bellini5, Elisabetta Fontanini6 per conto del Gruppo di Studio SIBioC Emostasi e Trombosi
1Synlab Italia
2SC Laboratorio Analisi Chimico-cliniche e Microbiologia - AO Ordine Mauriziano Torino
3UOC Laboratorio Patologia Clinica - Azienda Ospedaliero Universitaria Senese Policlinico Santa Maria alle Scotte, Siena
4Servizio di Medicina Trasfusionale Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste
5UOC Laboratorio Analisi Chimico-Cliniche, PO Misericordia Grosseto, Azienda USL Toscana Sud Est, Grosseto.
6Laboratorio Unico Interaziendale. Dipartimento di Medicina di Laboratorio, Azienda Sanitaria Universitaria Integrata di Udine, Udine

ABSTRACT

BIBLIOGRAFIA

  1. Morelli B, Montaruli B, Steffan A, Bonetti G, Cozzi MR, Calzoni P, et al. Recommendations for harmonization of the coagulation screening tests laboratory report. Biochim Clin 2023;47:377-85.
  2. Clinical and Laboratory Standard Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline — Second edition H47-A2, Wayne: CLSI; 2008.
  3. Chandler WL, ed. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013;63-71.
  4. Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzuca A, et al. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results – the Bologna oral anticoagulant control exercise. Thromb Haemost 1987;58:905-10.
  5. Peters RH, van den Besselaar AM, Olthuis FM. Determination of the mean normal prothrombin time for assessment of international normalized ratios. Usefulness of lyophilized plasma. Thromb Haemost 1991;66:442-5.
  6. Rapaport SI, Vermylen J, Hoylaerts M, Saito H, Hirsh J, Bates S, et al. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost. 2004;2:2250-9.
  7. Kershaw G. Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants. Methods Mol Biol 2017;1646:75-83.
  8. Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Makie I, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 2020;18:2828-39.
  9. Plebani M. Harmonization in laboratory medicine: requests, samples, measurements and reports. Crit Revs Clin Lab Sci 2016;53:184-96.
  10. Miller WG, Tate JR, Barth JH, Jones GRD. Harmonization: the sample, the measurement, and the report. Ann Lab Med 2014;34:187-97.
  11. Ceriotti F. Standardizzazione e armonizzazione: SIBioC in prima linea. Biochim Clin 2015;39:48-55.
  12. AAVV. SIBioC 2023 Strategic Conference. Il futuro della Medicina di Laboratorio. Biochim Clin 2023;47 Suppl2.